Works by Thomas, Deborah


Results: 257
    1
    2
    3
    4
    5
    6
    7
    8

    Herskovits at the Heart of Blackness.

    Published in:
    Journal of Latin American & Caribbean Anthropology, 2012, v. 17, n. 2, p. 389, doi. 10.1111/j.1935-4940.2012.01247.x
    By:
    • Thomas, Deborah A.
    Publication type:
    Article
    9
    10
    11

    Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 1, p. 91, doi. 10.1002/ajh.24947
    By:
    • Abaza, Yasmin;
    • M. Kantarjian, Hagop;
    • Faderl, Stefan;
    • Jabbour, Elias;
    • Jain, Nitin;
    • Thomas, Deborah;
    • Kadia, Tapan;
    • Borthakur, Gautam;
    • D. Khoury, Joseph;
    • Burger, Jan;
    • Wierda, William;
    • O'Brien, Susan;
    • Konopleva, Marina;
    • Ferrajoli, Alessandra;
    • Kebriaei, Partow;
    • Dabaja, Bouthaina;
    • Kornblau, Steven;
    • Alvarado, Yesid;
    • Daver, Naval;
    • Pemmaraju, Naveen
    Publication type:
    Article
    12

    Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 6, p. E114, doi. 10.1002/ajh.24720
    By:
    • Short, Nicholas J.;
    • Kantarjian, Hagop M.;
    • Ko, Heidi;
    • Khoury, Joseph D.;
    • Ravandi, Farhad;
    • Thomas, Deborah A.;
    • Garcia-Manero, Guillermo;
    • Khouri, Maria;
    • Cortes, Jorge E.;
    • Wierda, William G.;
    • Verstovsek, Srdan;
    • Estrov, Zeev;
    • Ferrajoli, Alessandra;
    • Thompson, Philip A.;
    • Pierce, Sherry;
    • O'Brien, Susan M.;
    • Jabbour, Elias
    Publication type:
    Article
    13

    Poor outcomes associated with +der(22)t(9;22) and −9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 3, p. 238, doi. 10.1002/ajh.24625
    By:
    • Short, Nicholas J.;
    • Kantarjian, Hagop M.;
    • Sasaki, Koji;
    • Ravandi, Farhad;
    • Ko, Heidi;
    • Cameron Yin, C.;
    • Garcia-Manero, Guillermo;
    • Cortes, Jorge E.;
    • Garris, Rebecca;
    • O'Brien, Susan M.;
    • Patel, Keyur;
    • Khouri, Maria;
    • Thomas, Deborah;
    • Jain, Nitin;
    • Kadia, Tapan M.;
    • Daver, Naval G.;
    • Benton, Christopher B.;
    • Issa, Ghayas C.;
    • Konopleva, Marina;
    • Jabbour, Elias
    Publication type:
    Article
    14

    Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 3, p. 279, doi. 10.1002/ajh.24629
    By:
    • Pemmaraju, Naveen;
    • Kantarjian, Hagop;
    • Jorgensen, Jeffrey L.;
    • Jabbour, Elias;
    • Jain, Nitin;
    • Thomas, Deborah;
    • O'Brien, Susan;
    • Wang, Xuemei;
    • Huang, Xuelin;
    • Wang, Sa A.;
    • Konopleva, Marina;
    • Konoplev, Sergej;
    • Kadia, Tapan;
    • Garris, Rebecca;
    • Pierce, Sherry;
    • Garcia-Manero, Guillermo;
    • Cortes, Jorge;
    • Ravandi, Farhad
    Publication type:
    Article
    15

    Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 8, p. 800, doi. 10.1002/ajh.24415
    By:
    • Badar, Talha;
    • Handisides, Damian R.;
    • Benito, Juliana M.;
    • Richie, Mary Ann;
    • Borthakur, Gautam;
    • Jabbour, Elias;
    • Harutyunyan, Karine;
    • Konoplev, Sergej;
    • Faderl, Stefan;
    • Kroll, Stew;
    • Andreeff, Michael;
    • Pearce, Tillman;
    • Kantarjian, Hagop M.;
    • Cortes, Jorge E.;
    • Thomas, Deborah A.;
    • Konopleva, Marina
    Publication type:
    Article
    16

    Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 8, p. 819, doi. 10.1002/ajh.24419
    By:
    • Rytting, Michael E.;
    • Jabbour, Elias J.;
    • Jorgensen, Jeffrey L.;
    • Ravandi, Farhad;
    • Franklin, Anna R.;
    • Kadia, Tapan M.;
    • Pemmaraju, Naveen;
    • Daver, Naval G.;
    • Ferrajoli, Alessandra;
    • Garcia-Manero, Guillermo;
    • Konopleva, Marina Y.;
    • Borthakur, Gautam;
    • Garris, Rebecca;
    • Wang, Sa;
    • Pierce, Sherry;
    • Schroeder, Kurt;
    • Kornblau, Steven M.;
    • Thomas, Deborah A.;
    • Cortes, Jorge E.;
    • O'Brien, Susan M.
    Publication type:
    Article
    17
    18

    Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone ( MOp AD) in patients with relapsed/refractory acute lymphoblastic leukemia.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 2, p. 120, doi. 10.1002/ajh.23886
    By:
    • Kadia, Tapan M.;
    • Kantarjian, Hagop M.;
    • Thomas, Deborah A.;
    • O'Brien, Susan;
    • Estrov, Zeev;
    • Ravandi, Farhad;
    • Jabbour, Elias;
    • Pemmaraju, Naveen;
    • Daver, Naval;
    • Wang, Xuemei;
    • Jain, Preetesh;
    • Pierce, Sherry;
    • Brandt, Mark;
    • Garcia-Manero, Guillermo;
    • Cortes, Jorge;
    • Borthakur, Gautam
    Publication type:
    Article
    19

    Phase II trial of HyperCVAD and Dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 3, p. 282, doi. 10.1002/ajh.23624
    By:
    • Benjamini, Ohad;
    • Dumlao, Theresa Liu;
    • Kantarjian, Hagop;
    • O'Brien, Susan;
    • Garcia-Manero, Guillermo;
    • Faderl, Stefan;
    • Jorgensen, Jeffrey;
    • Luthra, Rajyalakshmi;
    • Garris, Rebecca;
    • Thomas, Deborah;
    • Kebriaei, Partow;
    • Champlin, Richard;
    • Jabbour, Elias;
    • Burger, Jan;
    • Cortes, Jorge;
    • Ravandi, Farhad
    Publication type:
    Article
    20
    21

    Prediction model for mortality after intracranial hemorrhage in patients with leukemia.

    Published in:
    American Journal of Hematology, 2011, v. 86, n. 7, p. 546, doi. 10.1002/ajh.22031
    By:
    • Dayyani, Farshid;
    • Mougalian, Sarah Schellhorn;
    • Naqvi, Kiran;
    • Shan, Jianqin;
    • Ravandi, Farhad;
    • Cortes, Jorge;
    • Weinberg, Jeffrey;
    • Jabbour, Elias;
    • Faderl, Stefan;
    • Wierda, William;
    • Thomas, Deborah;
    • O'Brien, Susan;
    • Pierce, Sherry;
    • Kantarjian, Hagop;
    • Garcia-Manero, Guillermo
    Publication type:
    Article
    22
    23
    24

    Advances in the Therapy of Chronic Idiopathic Myelofibrosis.

    Published in:
    Oncologist, 2006, v. 11, n. 8, p. 929, doi. 10.1634/theoncologist.11-8-929
    By:
    • ARANA-YI, CECILIA;
    • QUINTÁS-CARDAMA, ALFONSO;
    • GILES, FRANCIS;
    • THOMAS, DEBORAH;
    • CARRASCO-YALAN, ANTONIO;
    • CORTES, JORGE;
    • KANTARJIAN, HAGOP;
    • VERSTOVSEK, SRDAN
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31

    Sick-Day Guidelines.

    Published in:
    Clinical Diabetes, 2000, v. 18, n. 3, p. 138
    By:
    • Thomas-Dobersen, Deborah
    Publication type:
    Article
    32
    33
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50